vTv Therapeutics (VTVT) Other financing activities (2021 - 2025)
vTv Therapeutics' (VTVT) quarterly Other financing activities came in at $7000.0 in Q4 2025, down 85.11% quarter-over-quarter from $47000.0 in Q1 2021.
Powered by 
Analysis
vTv Therapeutics (VTVT) Other financing activities (2021 - 2025) Analysis & Trends
vTv Therapeutics has disclosed Other financing activities across 2 years of filings, most recently posting $7000.0 for Q4 2025.
- In Q4 2025, Other financing activities changed N/A year-over-year to $7000.0; the TTM figure through Dec 2025 stood at $7000.0 (changed N/A YoY), while the FY2025 annual figure was $16000.0, changed N/A from the prior year.
- Other financing activities came in at $7000.0 for Q4 2025 at vTv Therapeutics, down from $47000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $47000.0 in Q1 2021 to a low of $7000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |